InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Grifols SA

GRFS Clue Score47
United States CIK 0001438569
$7.37 -1.21% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.37 −46.09% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue4.05Operating income0.94Net income0.55EPS, diluted0.80Fiscal year 2017Revenue4.32 +6.6%Operating income1.00Net income0.66 +21.5%EPS, diluted0.97 +21.2%Fiscal year 2018Revenue4.49 +3.9%Operating income0.99Net income0.60 −10.0%EPS, diluted0.87 −10.3%Fiscal year 2019Revenue5.10 +13.6%Operating income1.13Net income0.63 +4.8%EPS, diluted0.91 +4.6%Fiscal year 2020Revenue5.34 +4.7%Operating income1.00Net income0.62 −1.1%EPS, diluted0.90 −1.1%Fiscal year 2021Revenue4.93 −7.6%Operating income0.60Net income0.19 −69.5%EPS, diluted0.28 −68.9%Fiscal year 2022Revenue6.06 +22.9%Operating income0.78Net income0.19 −2.0%EPS, diluted0.27 −3.6%Fiscal year 2023Revenue6.59 +8.7%Operating income0.78Net income0.04 −77.1%EPS, diluted0.06 −77.8%Fiscal year 2024Revenue7.21 +9.4%Operating income1.19Net income0.16 +270.8%EPS, diluted0.23 +283.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Revenue 4.05 4.32 4.49 5.10 5.34 4.93 6.06 6.59 7.21
Growth +6.6% +3.9% +13.6% +4.7% −7.6% +22.9% +8.7% +9.4%
Operating income 0.94 1.00 0.99 1.13 1.00 0.60 0.78 0.78 1.19
Net income 0.55 0.66 0.60 0.63 0.62 0.19 0.19 0.04 0.16
Growth +21.5% −10.0% +4.8% −1.1% −69.5% −2.0% −77.1% +270.8%
EPS, diluted 0.80 0.97 0.87 0.91 0.90 0.28 0.27 0.06 0.23
Growth +21.2% −10.3% +4.6% −1.1% −68.9% −3.6% −77.8% +283.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin47.2%Operating margin23.2%Net margin13.5%Free cash flow margin7.5%Fiscal year 2017Gross margin49.8%Operating margin23.2%Net margin15.3%Free cash flow margin13.7%Fiscal year 2018Gross margin45.7%Operating margin22.2%Net margin13.3%Free cash flow margin11.3%Fiscal year 2019Gross margin45.9%Operating margin22.2%Net margin12.3%Free cash flow margin5.1%Fiscal year 2020Gross margin42.2%Operating margin18.7%Net margin11.6%Free cash flow margin15.5%Fiscal year 2021Gross margin39.8%Operating margin12.1%Net margin3.8%Free cash flow margin7.1%Fiscal year 2022Gross margin36.5%Operating margin12.9%Net margin3.1%Free cash flow margin−4.7%Fiscal year 2023Gross margin37.7%Operating margin11.9%Net margin0.6%Free cash flow margin−0.1%Fiscal year 2024Gross margin38.7%Operating margin16.5%Net margin2.2%Free cash flow margin9.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Gross margin 47.2% 49.8% 45.7% 45.9% 42.2% 39.8% 36.5% 37.7% 38.7%
Operating margin 23.2% 23.2% 22.2% 22.2% 18.7% 12.1% 12.9% 11.9% 16.5%
Net margin 13.5% 15.3% 13.3% 12.3% 11.6% 3.8% 3.1% 0.6% 2.2%
Free cash flow margin 7.5% 13.7% 11.3% 5.1% 15.5% 7.1% −4.7% −0.1% 9.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow0.55Capital expenditure−0.25Free cash flow0.30Buybacks−0.01Fiscal year 2017Operating cash flow0.84Capital expenditure−0.25Free cash flow0.59 +94.2%Fiscal year 2018Operating cash flow0.74Capital expenditure−0.23Free cash flow0.51 −14.4%Dividends paid−0.14Fiscal year 2019Operating cash flow0.57Capital expenditure−0.31Free cash flow0.26 −48.8%Dividends paid−0.24Fiscal year 2020Operating cash flow1.11Capital expenditure−0.28Free cash flow0.83 +221.1%Dividends paid−0.11Fiscal year 2021Operating cash flow0.60Capital expenditure−0.25Free cash flow0.35 −57.9%Buybacks−0.13Dividends paid−0.26Fiscal year 2022Operating cash flow−0.00Capital expenditure−0.28Free cash flow−0.29 −181.6%Buybacks−0.00Dividends paid−0.00Fiscal year 2023Operating cash flow0.22Capital expenditure−0.22Free cash flow−0.01Buybacks0.00Dividends paid0.00Fiscal year 2024Operating cash flow0.90Capital expenditure−0.23Free cash flow0.67Dividends paid−0.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Operating cash flow 0.55 0.84 0.74 0.57 1.11 0.60 −0.00 0.22 0.90
Capital expenditure −0.25 −0.25 −0.23 −0.31 −0.28 −0.25 −0.28 −0.22 −0.23
Free cash flow 0.30 0.59 0.51 0.26 0.83 0.35 −0.29 −0.01 0.67
Growth +94.2% −14.4% −48.8% +221.1% −57.9% −181.6%
Buybacks −0.01 n/a n/a n/a n/a −0.13 −0.00 0.00 n/a
Dividends paid n/a n/a −0.14 −0.24 −0.11 −0.26 −0.00 0.00 −0.00

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.90Shareholders’ equity3.72Fiscal year 2017Cash0.89Total debt5.02Net cash (debt)−4.13Shareholders’ equity3.63Debt to equity1.38Fiscal year 2018Cash1.03Total debt5.01Net cash (debt)−3.98Shareholders’ equity4.23Debt to equity1.19Fiscal year 2019Cash0.74Total debt3.50Net cash (debt)−2.76Shareholders’ equity4.82Debt to equity0.73Fiscal year 2020Cash0.58Total debt3.30Net cash (debt)−2.72Shareholders’ equity5.11Debt to equity0.65Fiscal year 2021Cash2.68Total debt3.58Net cash (debt)−0.90Shareholders’ equity5.52Debt to equity0.65Fiscal year 2022Cash0.55Total debt3.59Net cash (debt)−3.04Shareholders’ equity5.65Debt to equity0.64Fiscal year 2023Cash0.53Total debt3.65Net cash (debt)−3.12Shareholders’ equity5.37Debt to equity0.68Fiscal year 2024Cash0.98Total debt2.34Net cash (debt)−1.36Shareholders’ equity5.88Debt to equity0.40
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Cash 0.90 0.89 1.03 0.74 0.58 2.68 0.55 0.53 0.98
Total debt n/a 5.02 5.01 3.50 3.30 3.58 3.59 3.65 2.34
Net cash (debt) n/a −4.13 −3.98 −2.76 −2.72 −0.90 −3.04 −3.12 −1.36
Shareholders’ equity 3.72 3.63 4.23 4.82 5.11 5.52 5.65 5.37 5.88
Debt to equity n/a 1.38 1.19 0.73 0.65 0.65 0.64 0.68 0.40

In billions of EUR, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Balance sheet

In billions of EUR, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024
Assets
0.90 0.89 1.03 0.74 0.58 2.68 0.55 0.53 0.98
0.53 0.39 0.40 0.49 0.52 0.50 0.74 0.77 0.84
1.64 1.63 1.95 2.34 2.00 2.26 3.24 3.48 3.56
1.81 1.76 1.95 2.16 2.32 2.55 3.30 3.25 3.34
3.64 4.59 5.21 5.51 5.33 6.23 7.01 6.80 7.40
10.13 10.92 12.48 15.54 15.27 19.23 21.23 20.99 21.41
Growth +7.8% +14.3% +24.6% −1.7% +25.9% +10.4% −1.1% +2.0%
Liabilities
n/a 5.02 5.01 3.50 3.30 3.58 3.59 3.65 2.34
calc n/a 5.02 5.01 3.50 3.30 3.58 3.59 3.65 2.34
6.40 7.29 7.78 8.70 8.55 11.92 13.25 13.48 12.80
Equity
3.72 3.63 4.23 4.82 5.11 5.52 5.65 5.37 5.88
Growth −2.5% +16.4% +14.1% +5.9% +8.1% +2.3% −5.0% +9.6%
Per share and net cash
calc n/a −4.13 −3.98 −2.76 −2.72 −0.90 −3.04 −3.12 −1.36

Lines marked calc are worked out here from filed figures; point at one for how. Shown in EUR as filed; the screener converts to dollars.